Topical application of spiperone or derivatives thereof for trea

Details Topical application of spiperone or derivatives thereof for trea Topical application of spiperone or derivatives thereof for trea

1992-02-05

1993-09-14

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514885, A61K 3144

Patent

active

052449025

ABSTRACT:
A method for the treatment of a cutaneous, ocular, or mucosal pathological condition which is associated with immune response in a human or other mammal, that includes topical application of an effective amount of spiperone or a spiperone derivative or its pharmaceutically acceptable salt, in a pharmaceutically-acceptable diluent or carrier for topical application.

REFERENCES:
patent: 2788309 (1957-04-01), Cooper
patent: 2854380 (1958-09-01), Janssen et al.
patent: 3155669 (1964-11-01), Janssen et al.
patent: 3155670 (1964-11-01), Janssen et al.
patent: 3161644 (1964-12-01), Janssen et al.
patent: 3238216 (1966-03-01), Janssen et al.
patent: 3996363 (1976-12-01), Wade et al.
patent: 4839342 (1989-06-01), Kaswan
patent: 4874766 (1989-10-01), Ooms et al.
Ameisen, et al., "A New Interpretation of the Involvement of Serotonin in Delayed-Type Hypersensitivity," The Journal of Immunology, 142(9) 3171-3179 (1989).
Blozvski, et al., Arch. Intern. Pharmacodynamie, 123, 58-66 (1959), Chemical Abstracts, 54, Abstract 215049-i (1960).
Burka, et al., "Dopaminergic (Co-Mediator) Modulation of Release of Histamine and SRS-A in the Calf," British Journal of Pharmacology, 58(3) 445 (1976).
Eyre, "Dopamine Potentiates Anaphylactic Contraction of Pulmonary Vein of Calf," Research Communications in Chemical Pathology and Pharmacology, 22(3) 447-453 (1978).
Hellstrand, et al., "A Role of Serotonin in the Regulation of Human Natural Killer Cell Cytotoxicity," The Journal of Immunology 139(3) 869-875 (1987).
Levsen, et al., "Receptor Binding of R 41 468, A Novel Antagonist at 5-HT2 Receptors," Life Sciences, 28(9) 1015-1022 (1981).
Loffman, et al., American Heart Journal, 74(2), 229-234 (1967), Chemical Abstracts, 67 Abstract 81019W (1967).
Moerlein et al., "Effect of Lipophilicity on the In Vivo Localization of Radiolabelled Spiperone Analogues", Int. J. Nucl. Med. Biol. 12, 353-56 (1985).
Sternberger, et al., "Macrophase Activation by Serotonin (5-HT) is Affected by Interferon Concentration and is Antagonized by Spiperone and Ketanserin," Fed. Proc. 44(5) 7526 (1985).
Chemical Abstracts 75:110315n, 1971 (Nakanishi).

Affiliated with

Also associated with

Rating

Topical application of spiperone or derivatives thereof for trea does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical application of spiperone or derivatives thereof for trea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical application of spiperone or derivatives thereof for trea will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2026738